» Authors » Sayan Dasgupta

Sayan Dasgupta

Explore the profile of Sayan Dasgupta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 269
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Gabert R, Lama J, Valdez R, Dasgupta S, Cabello R, Sanchez H, et al.
AIDS . 2023 Feb; 37(7):1103-1108. PMID: 36779502
Objectives: To describe the prevalence of acute retroviral syndrome (ARS) and associated findings during primary HIV, and explore the relationship of ARS to clinical, virological, and immunological outcomes within a...
12.
Bender Ignacio R, Dasgupta S, Valdez R, Pandey U, Pasalar S, Alfaro R, et al.
iScience . 2022 Dec; 25(12):105632. PMID: 36483014
Prior studies attempting to link biomarkers of immune activation with risk of acquiring HIV have relied on cross sectional samples, most without proximity to HIV acquisition. We created a nested...
13.
Gilada T, Schnittman S, White E, Mercader J, Wang Y, Dasgupta S, et al.
Open Forum Infect Dis . 2022 May; 9(6):ofac155. PMID: 35611350
Background: Primary human immunodeficiency virus (HIV) is characterized by dynamic changes in viral load and innate and adaptive immune responses; it is unclear the extent to which time from acquisition...
14.
Massanella M, Bender Ignacio R, Lama J, Pagliuzza A, Dasgupta S, Alfaro R, et al.
Lancet Microbe . 2022 May; 2(5):e198-e209. PMID: 35544209
Background: Early antiretroviral therapy (ART) initiation (ie, within 3 months of infection) limits establishment of the HIV reservoir. However, the effect of early ART initiation on the long-term dynamics of...
15.
Josyula S, Pont M, Dasgupta S, Song X, Thomas S, Pepper G, et al.
Transplant Cell Ther . 2022 Mar; 28(6):304.e1-304.e9. PMID: 35288345
Chimeric antigen receptor (CAR) T cell therapy targeting B cell maturation antigen (BCMA-CARTx) is an emerging treatment for relapsed or refractory multiple myeloma (R/R MM). Here we characterize the epidemiology...
16.
Long J, Tordoff D, Reisner S, Dasgupta S, Mayer K, Mullins J, et al.
Lancet Reg Health Am . 2022 Feb; 6. PMID: 35178526
Background: Transgender women (TW) in Peru are disproportionately affected by HIV. The role that cisgender men who have sex with TW (MSTW) and their sexual networks play in TW's risk...
17.
Long J, Sanchez H, Dasgupta S, Huerta L, Garcia D, Lama J, et al.
J Acquir Immune Defic Syndr . 2022 Jan; 90(1):1-5. PMID: 35044990
Background: Knowledge of HIV status is a critical first step in the HIV care cascade. Cisgender male sex partners of transgender women (MSTW) are at a disproportionately high risk of...
18.
De Sarkar N, Dasgupta S, Chatterjee P, Coleman I, Ha G, Ang L, et al.
JCI Insight . 2021 Dec; 6(23). PMID: 34877933
Cancers with homology-directed DNA repair (HRR) deficiency exhibit high response rates to poly(ADP-ribose) polymerase inhibitors (PARPi) and platinum chemotherapy. Though mutations disrupting BRCA1 and BRCA2 associate with HRR deficiency (HRRd),...
19.
Massanella M, Bender Ignacio R, Lama J, Pagliuzza A, Dasgupta S, Alfaro R, et al.
Lancet Microbe . 2021 Nov; 2(5):e198-e209. PMID: 34841369
Background: Early antiretroviral therapy (ART) initiation (ie, within 3 months of infection) limits establishment of the HIV reservoir. However, the effect of early ART initiation on the long-term dynamics of...
20.
Dasgupta S, Moore M, Dimitrov D, Hughes J
Epidemics . 2021 Nov; 37:100514. PMID: 34763161
Complex models of infectious diseases are used to understand the transmission dynamics of the disease, project the course of an epidemic, predict the effect of interventions and/or provide information for...